Azebiotics

Discovery and development of novel antibiotics to treat multidrug-resistant infections. 

Azebiotics2023-07-20T11:46:12+00:00

Zentexia

Specialized in fusion molecules based on secondary metabolites from eukaryotes.

Zentexia2023-07-20T11:46:28+00:00

Henlez

Develops enzyme-powered topical products for improved management of skin conditions

Henlez2023-07-20T11:46:45+00:00

Arxx Therapeutics

Arxx Therapeutics develops a first-in-class monoclonal antibody with a unique mechanism of action targeting non-resolving tissue fibrosis

Arxx Therapeutics2023-07-20T11:45:03+00:00
Go to Top